Referenced in: none

Automatically associated channels: Kir2.1 , Kv11.1 , Kv7.1

Title: Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome.

Authors: Daniel Toshio Harrell, Takashi Ashihara, Taisuke Ishikawa, Ichiko Tominaga, Andrea Mazzanti, Kazuhiro Takahashi, Yasushi Oginosawa, Haruhiko Abe, Koji Maemura, Naokata Sumitomo, Kikuya Uno, Makoto Takano, Silvia G Priori, Naomasa Makita

Journal, date & volume: Int. J. Cardiol., 2015 Jul 1 , 190, 393-402

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/25974115

Abstract
Short QT syndrome (SQTS) is a rare inheritable arrhythmia, associated with atrial and ventricular fibrillations, caused by mutations in six cardiac ion channel genes with high penetrance. However, genotype-specific clinical differences between SQTS patients remain to be elucidated.We screened five unrelated Japanese SQTS families, and identified three mutations in KCNH2 and KCNQ1. A novel mutation KCNH2-I560T, when expressed in COS-7 cells, showed a 2.5-fold increase in peak current density, and a positive shift (+14 mV) of the inactivation curve compared with wild type. Computer simulations recapitulated the action potential shortening and created an arrhythmogenic substrate for ventricular fibrillation. In another family carrying the mutation KCNQ1-V141M, affected members showed earlier onset of manifestation and frequent complications of bradyarrhythmia. To determine genotype-specific phenotypes in SQT1 (KCNH2), SQT2 (KCNQ1), and other subtypes SQT3-6, we analyzed clinical variables in 65 mutation-positive patients among all the 132 SQTS cases previously reported. The age of manifestation was significantly later in SQT1 (SQT1: 35 ± 19 years, n = 30; SQT2: 17 ± 25 years, n = 8, SQT3-6: 19 ± 15 years, n = 15; p = 0.011). SQT2 exhibited a higher prevalence of bradyarrhythmia (SQT2: 6/8, 75%; non-SQT2: 5/57, 9%; p < 0.001) and atrial fibrillation (SQT2: 5/8, 63%; non-SQT2: 12/57, 21%; p = 0.012). Of 51 mutation-positive individuals from 16 SQTS families, nine did not manifest short QT, but exhibited other ECG abnormalities such as atrial fibrillation. The resulting penetrance, 82%, was lower than previously recognized.We propose that SQTS patients may exhibit different clinical manifestations depending upon their genotype.